Form 8-K - Current report:
SEC Accession No. 0001628280-21-011401
Filing Date
2021-06-01
Accepted
2021-06-01 10:52:26
Documents
52
Period of Report
2021-06-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k060121.htm 8-K 28434
2 EX-99.1 a991ex060121.htm EX-99.1 54109
3 GRAPHIC a991ex060121001.jpg GRAPHIC 52160
4 GRAPHIC a991ex060121002.jpg GRAPHIC 231119
5 GRAPHIC a991ex060121003.jpg GRAPHIC 56184
6 GRAPHIC a991ex060121004.jpg GRAPHIC 82651
7 GRAPHIC a991ex060121005.jpg GRAPHIC 165177
8 GRAPHIC a991ex060121006.jpg GRAPHIC 83463
9 GRAPHIC a991ex060121007.jpg GRAPHIC 58677
10 GRAPHIC a991ex060121008.jpg GRAPHIC 114880
11 GRAPHIC a991ex060121009.jpg GRAPHIC 73716
12 GRAPHIC a991ex060121010.jpg GRAPHIC 116165
13 GRAPHIC a991ex060121011.jpg GRAPHIC 112090
14 GRAPHIC a991ex060121012.jpg GRAPHIC 83125
15 GRAPHIC a991ex060121013.jpg GRAPHIC 47405
16 GRAPHIC a991ex060121014.jpg GRAPHIC 141984
17 GRAPHIC a991ex060121015.jpg GRAPHIC 100632
18 GRAPHIC a991ex060121016.jpg GRAPHIC 101427
19 GRAPHIC a991ex060121017.jpg GRAPHIC 120783
20 GRAPHIC a991ex060121018.jpg GRAPHIC 77016
21 GRAPHIC a991ex060121019.jpg GRAPHIC 107166
22 GRAPHIC a991ex060121020.jpg GRAPHIC 119298
23 GRAPHIC a991ex060121021.jpg GRAPHIC 120470
24 GRAPHIC a991ex060121022.jpg GRAPHIC 102749
25 GRAPHIC a991ex060121023.jpg GRAPHIC 105046
26 GRAPHIC a991ex060121024.jpg GRAPHIC 146369
27 GRAPHIC a991ex060121025.jpg GRAPHIC 118750
28 GRAPHIC a991ex060121026.jpg GRAPHIC 126583
29 GRAPHIC a991ex060121027.jpg GRAPHIC 95277
30 GRAPHIC a991ex060121028.jpg GRAPHIC 122546
31 GRAPHIC a991ex060121029.jpg GRAPHIC 104563
32 GRAPHIC a991ex060121030.jpg GRAPHIC 73964
33 GRAPHIC a991ex060121031.jpg GRAPHIC 123898
34 GRAPHIC a991ex060121032.jpg GRAPHIC 111669
35 GRAPHIC a991ex060121033.jpg GRAPHIC 76502
36 GRAPHIC a991ex060121034.jpg GRAPHIC 64562
37 GRAPHIC a991ex060121035.jpg GRAPHIC 110635
38 GRAPHIC a991ex060121036.jpg GRAPHIC 135619
39 GRAPHIC a991ex060121037.jpg GRAPHIC 117135
40 GRAPHIC a991ex060121038.jpg GRAPHIC 163056
41 GRAPHIC a991ex060121039.jpg GRAPHIC 157306
42 GRAPHIC a991ex060121040.jpg GRAPHIC 143935
43 GRAPHIC a991ex060121041.jpg GRAPHIC 92643
44 GRAPHIC a991ex060121042.jpg GRAPHIC 37986
45 GRAPHIC a991ex060121043.jpg GRAPHIC 96242
46 GRAPHIC a991ex060121044.jpg GRAPHIC 103199
47 GRAPHIC a991ex060121045.jpg GRAPHIC 91620
48 GRAPHIC a991ex060121046.jpg GRAPHIC 127730
49 GRAPHIC a991ex060121047.jpg GRAPHIC 115978
50 GRAPHIC a991ex060121048.jpg GRAPHIC 165274
51 GRAPHIC a991ex060121049.jpg GRAPHIC 53873
52 cardiff_logoxrgbxtm.jpg GRAPHIC 176318
  Complete submission text file 0001628280-21-011401.txt   7548282
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 21983561
SIC: 2836 Biological Products, (No Diagnostic Substances)